Bone marrow haematopoiesis in patients with COVID-19.
COVID-19
SARS-CoV-2
autopsy
haematology
pathology
Journal
Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
17
05
2023
received:
13
01
2023
accepted:
23
05
2023
medline:
13
9
2023
pubmed:
15
6
2023
entrez:
15
6
2023
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection broadly affects organ homeostasis, including the haematopoietic system. Autopsy studies are a crucial tool for investigation of organ-specific pathologies. Here we perform an in-depth analysis of the impact of severe coronavirus disease 2019 (COVID-19) on bone marrow haematopoiesis in correlation with clinical and laboratory parameters. Twenty-eight autopsy cases and five controls from two academic centres were included in the study. We performed a comprehensive analysis of bone marrow pathology and microenvironment features with clinical and laboratory parameters and assessed SARS-CoV-2 infection of the bone marrow by quantitative polymerase chain reaction (qPCR) analysis. In COVID-19 patients, bone marrow specimens showed a left-shifted myelopoiesis (19 of 28, 64%), increased myeloid-erythroid ratio (eight of 28, 28%), increased megakaryopoiesis (six of 28, 21%) and lymphocytosis (four of 28, 14%). Strikingly, a high proportion of COVID-19 specimens showed erythrophagocytosis (15 of 28, 54%) and the presence of siderophages (11 of 15, 73%) compared to control cases (none of five, 0%). Clinically, erythrophagocytosis correlated with lower haemoglobin levels and was more frequently observed in patients from the second wave. Analysis of the immune environment showed a strong increase in CD68+ macrophages (16 of 28, 57%) and a borderline lymphocytosis (five of 28, 18%). The stromal microenvironment showed oedema (two of 28, 7%) and severe capillary congestion (one of 28, 4%) in isolated cases. No stromal fibrosis or microvascular thrombosis was found. While all cases had confirmed positive testing of SARS-CoV-2 in the respiratory system, SARS-CoV-2 was not detected in the bone marrow by high-sensitivity PCR, suggesting that SARS-CoV-2 does not commonly replicate in the haematopoietic microenvironment. SARS-CoV-2 infection indirectly impacts the haematological compartment and the bone marrow immune environment. Erythrophagocytosis is frequent and associated with lower haemoglobin levels in patients with severe COVID-19.
Substances chimiques
Hemoglobins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
582-590Subventions
Organisme : Botnar Research Centre for Child Health, University of Basel
Organisme : Krebsliga Zürich
Organisme : Promedica Stiftung
Organisme : Stiftung Professor Dr. Max Cloëtta
Informations de copyright
© 2023 The Authors. Histopathology published by John Wiley & Sons Ltd.
Références
Schulte-Schrepping J, Reusch N, Paclik D et al. Severe Covid-19 is marked by a dysregulated myeloid cell compartment. Cell 2020; 182; 1419-1440. e1423.
Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395; 1054-1062.
Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir. Res. 2020; 21; 74.
Chen G, Wu D, Guo W et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020; 130; 2620-2629.
Shahbaz S, Xu L, Osman M et al. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell. Rep. 2021; 16; 1165-1181.
Yang M, Hon KL, Li K, Fok TF, Li CK. The effect of sars coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003; 11; 217-221.
Mehta P, McAuley DF, Brown M et al. Covid-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395; 1033-1034.
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in Covid-19 patients. Ann. Hematol. 2020; 99; 1205-1208.
Opoka-Winiarska V, Grywalska E, Rolinski J. Could hemophagocytic lymphohistiocytosis be the core issue of severe Covid-19 cases? BMC Med. 2020; 18; 214.
Ioannou M, Zacharouli K, Doukas SG et al. Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-Covid-19 patients: case report and mini-review. J. Mol. Histol. 2022; 53; 753-762.
Prilutskiy A, Kritselis M, Shevtsov A et al. SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis. Am. J. Clin. Pathol. 2020; 154; 466-474.
Nunez-Torron C, Ferrer-Gomez A, Moreno Moreno E et al. Secondary haemophagocytic lymphohistiocytosis in Covid-19: correlation of the autopsy findings of bone marrow haemophagocytosis with Hscore. J. Clin. Pathol. 2022; 75; 383-389.
Swoboda J, Wittschieber D, Sanft J et al. Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2. Histopathology 2021; 78; 727-737.
Harris CK, Hung YP, Nielsen GP, Stone JR, Ferry JA. Bone marrow and peripheral blood findings in patients infected by SARS-CoV-2. Am. J. Clin. Pathol. 2021; 155; 627-637.
Falasca L, Nardacci R, Colombo D et al. Postmortem findings in italian patients with Covid-19: a descriptive full autopsy study of cases with and without comorbidities. J. Infect. Dis. 2020; 222; 1807-1815.
Prieto-Perez L, Fortes J, Soto C et al. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in Covid-19 infection. Mod. Pathol. 2020; 33; 2139-2146.
Nienhold R, Ciani Y, Koelzer VH et al. Two distinct immunopathological profiles in autopsy lungs of Covid-19. Nat. Commun. 2020; 11; 5086.
Maccio U, Zinkernagel AS, Schuepbach R et al. Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 Covid-19 autopsies. Front. Med. (Lausanne) 2022; 9; 778489.
Travlos GS. Histopathology of bone marrow. Toxicol. Pathol. 2006; 34; 566-598.
Lee SH, Erber WN, Porwit A, Tomonaga M, Peterson LC, International Council for Standardization. ICSH guidelines for the standardization of bone marrow specimens and reports. Int. J. Lab. Hematol. 2008; 30; 349-364.
Perkins SL, Lee G, Foerster J. Wintrobe's clinical hematology. Platelets 2003; 16; 5.
Kaushansky K, Prchal JT, Burns LJ, Lichtman MA, Levi M, Linch DC eds. Williams hematology. 10th ed. New York: McGraw-Hill Education, 2021.
Swerdlow S, Campo E, Harris N et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 2017; 2017.
Jurek T, Rorat M, Szleszkowski L, Tokarski M, Pielka I, Malodobra-Mazur M. SARS-CoV-2 viral RNA is detected in the bone marrow in post-mortem samples using RT-LAMP. Diagnostics 2022; 12; 515.
De Ioris MA, Scarselli A, Bracaglia C et al. Common bone marrow signature in Covid-19-associated multisystem inflammatory syndrome in children: a first-wave small case series experience. Pediatr. Blood Cancer 2022; 69; e29919.
Lacinel Gurlevik S, Aksu T, Ozen S, Kesici S, Gumruk F, Ozsurekci Y. Hemophagocytosis in bone marrow aspirates in multisystem inflammatory syndrome in children. Pediatr. Blood Cancer 2021; 68; e28931.
Lam LKM, Murphy S, Kokkinaki D et al. DNA binding to tlr9 expressed by red blood cells promotes innate immune activation and anemia. Sci. Transl. Med. 2021; 13; eabj1008.
Purohit A, Vaswani S, Vishwajeet V et al. Evaluation of bone marrow findings of Covid-19 by minimally invasive autopsies: a single tertiary care centre experience from India. Indian J. Hematol. Blood Transfus. 2022; 38; 416-421.
Black S, Phillips D, Hickey JW et al. Codex multiplexed tissue imaging with DNA-conjugated antibodies. Nat. Protoc. 2021; 16; 3802-3835.
Koelzer VH, Sirinukunwattana K, Rittscher J, Mertz KD. Precision immunoprofiling by image analysis and artificial intelligence. Virchows Arch. 2019; 474; 511-522.
Devine RD, Behbehani GK. Mass cytometry, imaging mass cytometry, and multiplexed ion beam imaging use in a clinical setting. Clin. Lab. Med. 2021; 41; 297-308.